nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2D6—breast cancer	0.132	0.538	CbGaD
Almotriptan—FMO3—Tamoxifen—breast cancer	0.116	0.241	CbGbCtD
Almotriptan—CYP3A4—breast cancer	0.113	0.462	CbGaD
Almotriptan—CYP1A2—Anastrozole—breast cancer	0.026	0.0541	CbGbCtD
Almotriptan—CYP1A2—Toremifene—breast cancer	0.0238	0.0494	CbGbCtD
Almotriptan—CYP2C8—Lapatinib—breast cancer	0.0224	0.0466	CbGbCtD
Almotriptan—CYP2C19—Lapatinib—breast cancer	0.0188	0.0391	CbGbCtD
Almotriptan—CYP3A4—Exemestane—breast cancer	0.018	0.0374	CbGbCtD
Almotriptan—CYP2C8—Raloxifene—breast cancer	0.017	0.0353	CbGbCtD
Almotriptan—CYP2D6—Idarubicin—breast cancer	0.0162	0.0338	CbGbCtD
Almotriptan—CYP3A4—Letrozole—breast cancer	0.0153	0.0318	CbGbCtD
Almotriptan—CYP2E1—Tamoxifen—breast cancer	0.015	0.0312	CbGbCtD
Almotriptan—CYP2E1—Mitoxantrone—breast cancer	0.0146	0.0305	CbGbCtD
Almotriptan—CYP3A4—Anastrozole—breast cancer	0.0136	0.0283	CbGbCtD
Almotriptan—CYP3A4—Toremifene—breast cancer	0.0124	0.0259	CbGbCtD
Almotriptan—CYP3A4—Fulvestrant—breast cancer	0.0116	0.0241	CbGbCtD
Almotriptan—CYP2C8—Tamoxifen—breast cancer	0.0112	0.0233	CbGbCtD
Almotriptan—CYP3A4—Thiotepa—breast cancer	0.0103	0.0215	CbGbCtD
Almotriptan—CYP3A4—Ixabepilone—breast cancer	0.00943	0.0196	CbGbCtD
Almotriptan—CYP2C19—Tamoxifen—breast cancer	0.0094	0.0196	CbGbCtD
Almotriptan—CYP3A4—Lapatinib—breast cancer	0.00908	0.0189	CbGbCtD
Almotriptan—CYP2C8—Paclitaxel—breast cancer	0.00872	0.0182	CbGbCtD
Almotriptan—CYP1A2—Tamoxifen—breast cancer	0.00868	0.0181	CbGbCtD
Almotriptan—CYP2C8—Fluorouracil—breast cancer	0.00826	0.0172	CbGbCtD
Almotriptan—CYP2D6—Vinorelbine—breast cancer	0.00792	0.0165	CbGbCtD
Almotriptan—CYP2D6—Tamoxifen—breast cancer	0.00715	0.0149	CbGbCtD
Almotriptan—CYP3A4—Raloxifene—breast cancer	0.00688	0.0143	CbGbCtD
Almotriptan—CYP1A2—Fluorouracil—breast cancer	0.00639	0.0133	CbGbCtD
Almotriptan—CYP3A4—Vinorelbine—breast cancer	0.00504	0.0105	CbGbCtD
Almotriptan—CYP2D6—Vinblastine—breast cancer	0.00488	0.0102	CbGbCtD
Almotriptan—CYP3A4—Tamoxifen—breast cancer	0.00455	0.00946	CbGbCtD
Almotriptan—CYP3A4—Mitoxantrone—breast cancer	0.00443	0.00923	CbGbCtD
Almotriptan—CYP3A4—Paclitaxel—breast cancer	0.00354	0.00736	CbGbCtD
Almotriptan—CYP3A4—Irinotecan—breast cancer	0.00349	0.00727	CbGbCtD
Almotriptan—CYP3A4—Vinblastine—breast cancer	0.0031	0.00646	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—breast cancer	0.003	0.00624	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—breast cancer	0.00256	0.00532	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—breast cancer	0.00191	0.00397	CbGbCtD
Almotriptan—Melatonin—MT3—breast cancer	0.00101	0.233	CrCbGaD
Almotriptan—Melatonin—NQO2—breast cancer	0.000857	0.198	CrCbGaD
Almotriptan—Sumatriptan—SLCO1B1—breast cancer	0.000655	0.151	CrCbGaD
Almotriptan—FMO3—pituitary gland—breast cancer	0.000315	0.0618	CbGeAlD
Almotriptan—FMO3—adipose tissue—breast cancer	0.000314	0.0616	CbGeAlD
Almotriptan—Melatonin—CYP1B1—breast cancer	0.00029	0.0671	CrCbGaD
Almotriptan—Sumatriptan—ABCG2—breast cancer	0.000285	0.0659	CrCbGaD
Almotriptan—FMO3—adrenal gland—breast cancer	0.000281	0.0552	CbGeAlD
Almotriptan—CYP2C8—mammary gland—breast cancer	0.000269	0.0527	CbGeAlD
Almotriptan—MAOA—nipple—breast cancer	0.000249	0.0489	CbGeAlD
Almotriptan—FMO3—endocrine gland—breast cancer	0.000244	0.0479	CbGeAlD
Almotriptan—Melatonin—CYP19A1—breast cancer	0.000213	0.0493	CrCbGaD
Almotriptan—CYP1A2—nipple—breast cancer	0.000208	0.0408	CbGeAlD
Almotriptan—MAOA—embryo—breast cancer	0.000206	0.0404	CbGeAlD
Almotriptan—Eletriptan—PTGS1—breast cancer	0.000198	0.0457	CrCbGaD
Almotriptan—Melatonin—ESR1—breast cancer	0.000196	0.0453	CrCbGaD
Almotriptan—HTR1B—female reproductive system—breast cancer	0.000169	0.0332	CbGeAlD
Almotriptan—FMO3—lymph node—breast cancer	0.000169	0.0331	CbGeAlD
Almotriptan—HTR1D—female reproductive system—breast cancer	0.000164	0.0321	CbGeAlD
Almotriptan—Melatonin—CYP1A1—breast cancer	0.000157	0.0362	CrCbGaD
Almotriptan—MAOA—endometrium—breast cancer	0.000151	0.0295	CbGeAlD
Almotriptan—HTR1B—endocrine gland—breast cancer	0.000143	0.0281	CbGeAlD
Almotriptan—MAOA—uterus—breast cancer	0.000139	0.0272	CbGeAlD
Almotriptan—MAOA—pituitary gland—breast cancer	0.000136	0.0267	CbGeAlD
Almotriptan—MAOA—adipose tissue—breast cancer	0.000136	0.0266	CbGeAlD
Almotriptan—Eletriptan—CYP2D6—breast cancer	0.000135	0.0311	CrCbGaD
Almotriptan—CYP2C8—endometrium—breast cancer	0.000134	0.0263	CbGeAlD
Almotriptan—MAOA—female reproductive system—breast cancer	0.000125	0.0245	CbGeAlD
Almotriptan—MAOA—adrenal gland—breast cancer	0.000122	0.0239	CbGeAlD
Almotriptan—CYP2C8—pituitary gland—breast cancer	0.000121	0.0238	CbGeAlD
Almotriptan—Sumatriptan—ABCB1—breast cancer	0.000119	0.0274	CrCbGaD
Almotriptan—Eletriptan—CYP3A4—breast cancer	0.000115	0.0267	CrCbGaD
Almotriptan—MAOA—female gonad—breast cancer	0.000113	0.0223	CbGeAlD
Almotriptan—CYP2C8—female reproductive system—breast cancer	0.000111	0.0218	CbGeAlD
Almotriptan—CYP2C19—endocrine gland—breast cancer	0.000108	0.0212	CbGeAlD
Almotriptan—MAOA—endocrine gland—breast cancer	0.000106	0.0207	CbGeAlD
Almotriptan—Eletriptan—ABCB1—breast cancer	9.61e-05	0.0222	CrCbGaD
Almotriptan—CYP2C8—endocrine gland—breast cancer	9.41e-05	0.0185	CbGeAlD
Almotriptan—CYP2E1—female reproductive system—breast cancer	9.36e-05	0.0184	CbGeAlD
Almotriptan—CYP2E1—adrenal gland—breast cancer	9.13e-05	0.0179	CbGeAlD
Almotriptan—CYP1A2—endocrine gland—breast cancer	8.8e-05	0.0173	CbGeAlD
Almotriptan—CYP2E1—endocrine gland—breast cancer	7.92e-05	0.0155	CbGeAlD
Almotriptan—CYP3A4—female reproductive system—breast cancer	7.53e-05	0.0148	CbGeAlD
Almotriptan—CYP2D6—female reproductive system—breast cancer	7.41e-05	0.0145	CbGeAlD
Almotriptan—MAOA—lymph node—breast cancer	7.29e-05	0.0143	CbGeAlD
Almotriptan—CYP2D6—female gonad—breast cancer	6.74e-05	0.0132	CbGeAlD
Almotriptan—CYP3A4—endocrine gland—breast cancer	6.37e-05	0.0125	CbGeAlD
Almotriptan—CYP2D6—endocrine gland—breast cancer	6.27e-05	0.0123	CbGeAlD
Almotriptan—Hypoaesthesia—Epirubicin—breast cancer	4.92e-05	0.000282	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—breast cancer	4.91e-05	0.000282	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—breast cancer	4.91e-05	0.000281	CcSEcCtD
Almotriptan—Skin disorder—Capecitabine—breast cancer	4.9e-05	0.000281	CcSEcCtD
Almotriptan—Hyperhidrosis—Capecitabine—breast cancer	4.88e-05	0.00028	CcSEcCtD
Almotriptan—Body temperature increased—Paclitaxel—breast cancer	4.86e-05	0.000279	CcSEcCtD
Almotriptan—Abdominal pain—Paclitaxel—breast cancer	4.86e-05	0.000279	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—breast cancer	4.81e-05	0.000276	CcSEcCtD
Almotriptan—Vomiting—Irinotecan—breast cancer	4.79e-05	0.000275	CcSEcCtD
Almotriptan—Vomiting—Mitoxantrone—breast cancer	4.79e-05	0.000275	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—breast cancer	4.78e-05	0.000274	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—breast cancer	4.77e-05	0.000274	CcSEcCtD
Almotriptan—Dizziness—Fluorouracil—breast cancer	4.77e-05	0.000274	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—breast cancer	4.77e-05	0.000273	CcSEcCtD
Almotriptan—Rash—Mitoxantrone—breast cancer	4.75e-05	0.000273	CcSEcCtD
Almotriptan—Rash—Irinotecan—breast cancer	4.75e-05	0.000273	CcSEcCtD
Almotriptan—Dermatitis—Mitoxantrone—breast cancer	4.75e-05	0.000272	CcSEcCtD
Almotriptan—Dermatitis—Irinotecan—breast cancer	4.75e-05	0.000272	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—breast cancer	4.75e-05	0.000272	CcSEcCtD
Almotriptan—Chills—Methotrexate—breast cancer	4.74e-05	0.000272	CcSEcCtD
Almotriptan—Headache—Mitoxantrone—breast cancer	4.72e-05	0.000271	CcSEcCtD
Almotriptan—Headache—Irinotecan—breast cancer	4.72e-05	0.000271	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—breast cancer	4.71e-05	0.00027	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—breast cancer	4.68e-05	0.000268	CcSEcCtD
Almotriptan—Vomiting—Gemcitabine—breast cancer	4.67e-05	0.000268	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—breast cancer	4.65e-05	0.000266	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—breast cancer	4.63e-05	0.000266	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—breast cancer	4.63e-05	0.000266	CcSEcCtD
Almotriptan—Rash—Gemcitabine—breast cancer	4.63e-05	0.000266	CcSEcCtD
Almotriptan—Dermatitis—Gemcitabine—breast cancer	4.62e-05	0.000265	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—breast cancer	4.62e-05	0.000265	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—breast cancer	4.61e-05	0.000265	CcSEcCtD
Almotriptan—Erythema—Methotrexate—breast cancer	4.6e-05	0.000264	CcSEcCtD
Almotriptan—Headache—Gemcitabine—breast cancer	4.6e-05	0.000264	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Capecitabine—breast cancer	4.6e-05	0.000264	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—breast cancer	4.59e-05	0.000263	CcSEcCtD
Almotriptan—Vomiting—Fluorouracil—breast cancer	4.59e-05	0.000263	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—breast cancer	4.59e-05	0.000263	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—breast cancer	4.59e-05	0.000263	CcSEcCtD
Almotriptan—Insomnia—Capecitabine—breast cancer	4.56e-05	0.000262	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—breast cancer	4.55e-05	0.000261	CcSEcCtD
Almotriptan—Rash—Fluorouracil—breast cancer	4.55e-05	0.000261	CcSEcCtD
Almotriptan—Dermatitis—Fluorouracil—breast cancer	4.55e-05	0.000261	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—breast cancer	4.54e-05	0.000261	CcSEcCtD
Almotriptan—Paraesthesia—Capecitabine—breast cancer	4.53e-05	0.00026	CcSEcCtD
Almotriptan—Hypersensitivity—Paclitaxel—breast cancer	4.53e-05	0.00026	CcSEcCtD
Almotriptan—Headache—Fluorouracil—breast cancer	4.52e-05	0.000259	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—breast cancer	4.51e-05	0.000258	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—breast cancer	4.5e-05	0.000258	CcSEcCtD
Almotriptan—Dyspnoea—Capecitabine—breast cancer	4.5e-05	0.000258	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—breast cancer	4.49e-05	0.000258	CcSEcCtD
Almotriptan—Nausea—Mitoxantrone—breast cancer	4.48e-05	0.000257	CcSEcCtD
Almotriptan—Nausea—Irinotecan—breast cancer	4.48e-05	0.000257	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—breast cancer	4.47e-05	0.000256	CcSEcCtD
Almotriptan—Pain—Docetaxel—breast cancer	4.46e-05	0.000256	CcSEcCtD
Almotriptan—Back pain—Methotrexate—breast cancer	4.45e-05	0.000255	CcSEcCtD
Almotriptan—Dyspepsia—Capecitabine—breast cancer	4.44e-05	0.000255	CcSEcCtD
Almotriptan—Chills—Epirubicin—breast cancer	4.44e-05	0.000255	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—breast cancer	4.41e-05	0.000253	CcSEcCtD
Almotriptan—Asthenia—Paclitaxel—breast cancer	4.41e-05	0.000253	CcSEcCtD
Almotriptan—Nausea—Gemcitabine—breast cancer	4.36e-05	0.00025	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Capecitabine—breast cancer	4.36e-05	0.00025	CcSEcCtD
Almotriptan—Fatigue—Capecitabine—breast cancer	4.35e-05	0.000249	CcSEcCtD
Almotriptan—Pruritus—Paclitaxel—breast cancer	4.35e-05	0.000249	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—breast cancer	4.34e-05	0.000249	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—breast cancer	4.33e-05	0.000249	CcSEcCtD
Almotriptan—Pain—Capecitabine—breast cancer	4.31e-05	0.000247	CcSEcCtD
Almotriptan—Erythema—Epirubicin—breast cancer	4.31e-05	0.000247	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—breast cancer	4.29e-05	0.000246	CcSEcCtD
Almotriptan—Nausea—Fluorouracil—breast cancer	4.29e-05	0.000246	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—breast cancer	4.28e-05	0.000245	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—breast cancer	4.27e-05	0.000245	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—breast cancer	4.27e-05	0.000245	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—breast cancer	4.26e-05	0.000244	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—breast cancer	4.25e-05	0.000244	CcSEcCtD
Almotriptan—Tension—Epirubicin—breast cancer	4.23e-05	0.000242	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—breast cancer	4.22e-05	0.000242	CcSEcCtD
Almotriptan—Diarrhoea—Paclitaxel—breast cancer	4.21e-05	0.000241	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—breast cancer	4.18e-05	0.00024	CcSEcCtD
Almotriptan—Back pain—Epirubicin—breast cancer	4.17e-05	0.000239	CcSEcCtD
Almotriptan—Feeling abnormal—Capecitabine—breast cancer	4.16e-05	0.000238	CcSEcCtD
Almotriptan—Malaise—Methotrexate—breast cancer	4.15e-05	0.000238	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—breast cancer	4.13e-05	0.000237	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—breast cancer	4.13e-05	0.000237	CcSEcCtD
Almotriptan—Gastrointestinal pain—Capecitabine—breast cancer	4.12e-05	0.000237	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—breast cancer	4.12e-05	0.000236	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—breast cancer	4.12e-05	0.000236	CcSEcCtD
Almotriptan—Chills—Doxorubicin—breast cancer	4.11e-05	0.000236	CcSEcCtD
Almotriptan—Dizziness—Paclitaxel—breast cancer	4.06e-05	0.000233	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—breast cancer	4.06e-05	0.000233	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—breast cancer	4.01e-05	0.00023	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—breast cancer	4e-05	0.000229	CcSEcCtD
Almotriptan—Abdominal pain—Capecitabine—breast cancer	3.99e-05	0.000229	CcSEcCtD
Almotriptan—Body temperature increased—Capecitabine—breast cancer	3.99e-05	0.000229	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—breast cancer	3.99e-05	0.000229	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—breast cancer	3.98e-05	0.000229	CcSEcCtD
Almotriptan—Agitation—Epirubicin—breast cancer	3.96e-05	0.000227	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—breast cancer	3.92e-05	0.000225	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—breast cancer	3.92e-05	0.000225	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—breast cancer	3.92e-05	0.000225	CcSEcCtD
Almotriptan—Tension—Doxorubicin—breast cancer	3.91e-05	0.000224	CcSEcCtD
Almotriptan—Vomiting—Paclitaxel—breast cancer	3.91e-05	0.000224	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—breast cancer	3.9e-05	0.000224	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.89e-05	0.000223	CcSEcCtD
Almotriptan—Malaise—Epirubicin—breast cancer	3.88e-05	0.000223	CcSEcCtD
Almotriptan—Rash—Paclitaxel—breast cancer	3.88e-05	0.000222	CcSEcCtD
Almotriptan—Dermatitis—Paclitaxel—breast cancer	3.87e-05	0.000222	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—breast cancer	3.87e-05	0.000222	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—breast cancer	3.87e-05	0.000222	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—breast cancer	3.87e-05	0.000222	CcSEcCtD
Almotriptan—Syncope—Epirubicin—breast cancer	3.86e-05	0.000221	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—breast cancer	3.85e-05	0.000221	CcSEcCtD
Almotriptan—Headache—Paclitaxel—breast cancer	3.85e-05	0.000221	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—breast cancer	3.84e-05	0.00022	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—breast cancer	3.81e-05	0.000218	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—breast cancer	3.79e-05	0.000217	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—breast cancer	3.78e-05	0.000217	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—breast cancer	3.76e-05	0.000215	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—breast cancer	3.75e-05	0.000215	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—breast cancer	3.74e-05	0.000214	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—breast cancer	3.73e-05	0.000214	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—breast cancer	3.72e-05	0.000213	CcSEcCtD
Almotriptan—Hypersensitivity—Capecitabine—breast cancer	3.72e-05	0.000213	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—breast cancer	3.7e-05	0.000212	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—breast cancer	3.69e-05	0.000211	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—breast cancer	3.68e-05	0.000211	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—breast cancer	3.67e-05	0.00021	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—breast cancer	3.67e-05	0.00021	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—breast cancer	3.67e-05	0.00021	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—breast cancer	3.66e-05	0.00021	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—breast cancer	3.65e-05	0.00021	CcSEcCtD
Almotriptan—Nausea—Paclitaxel—breast cancer	3.65e-05	0.000209	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—breast cancer	3.65e-05	0.000209	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.64e-05	0.000209	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—breast cancer	3.63e-05	0.000208	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—breast cancer	3.62e-05	0.000208	CcSEcCtD
Almotriptan—Asthenia—Capecitabine—breast cancer	3.62e-05	0.000208	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—breast cancer	3.59e-05	0.000206	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—breast cancer	3.59e-05	0.000206	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—breast cancer	3.58e-05	0.000205	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—breast cancer	3.57e-05	0.000205	CcSEcCtD
Almotriptan—Pruritus—Capecitabine—breast cancer	3.57e-05	0.000205	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—breast cancer	3.56e-05	0.000204	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—breast cancer	3.54e-05	0.000203	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—breast cancer	3.52e-05	0.000202	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—breast cancer	3.51e-05	0.000202	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—breast cancer	3.5e-05	0.000201	CcSEcCtD
Almotriptan—Shock—Epirubicin—breast cancer	3.46e-05	0.000198	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—breast cancer	3.45e-05	0.000198	CcSEcCtD
Almotriptan—Diarrhoea—Capecitabine—breast cancer	3.45e-05	0.000198	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—breast cancer	3.45e-05	0.000198	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—breast cancer	3.45e-05	0.000198	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—breast cancer	3.44e-05	0.000197	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—breast cancer	3.43e-05	0.000197	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—breast cancer	3.42e-05	0.000196	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—breast cancer	3.41e-05	0.000196	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—breast cancer	3.4e-05	0.000195	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—breast cancer	3.4e-05	0.000195	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—breast cancer	3.39e-05	0.000195	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—breast cancer	3.39e-05	0.000195	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—breast cancer	3.39e-05	0.000195	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—breast cancer	3.38e-05	0.000194	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—breast cancer	3.37e-05	0.000193	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.37e-05	0.000193	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—breast cancer	3.35e-05	0.000192	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—breast cancer	3.35e-05	0.000192	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—breast cancer	3.34e-05	0.000191	CcSEcCtD
Almotriptan—Dizziness—Capecitabine—breast cancer	3.34e-05	0.000191	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—breast cancer	3.32e-05	0.00019	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—breast cancer	3.31e-05	0.00019	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—breast cancer	3.31e-05	0.00019	CcSEcCtD
Almotriptan—Rash—Docetaxel—breast cancer	3.29e-05	0.000188	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—breast cancer	3.28e-05	0.000188	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—breast cancer	3.28e-05	0.000188	CcSEcCtD
Almotriptan—Headache—Docetaxel—breast cancer	3.26e-05	0.000187	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—breast cancer	3.25e-05	0.000187	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—breast cancer	3.24e-05	0.000186	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—breast cancer	3.24e-05	0.000186	CcSEcCtD
Almotriptan—Pain—Methotrexate—breast cancer	3.21e-05	0.000184	CcSEcCtD
Almotriptan—Vomiting—Capecitabine—breast cancer	3.21e-05	0.000184	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—breast cancer	3.2e-05	0.000184	CcSEcCtD
Almotriptan—Shock—Doxorubicin—breast cancer	3.2e-05	0.000183	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—breast cancer	3.19e-05	0.000183	CcSEcCtD
Almotriptan—Rash—Capecitabine—breast cancer	3.18e-05	0.000182	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—breast cancer	3.18e-05	0.000182	CcSEcCtD
Almotriptan—Dermatitis—Capecitabine—breast cancer	3.18e-05	0.000182	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—breast cancer	3.17e-05	0.000182	CcSEcCtD
Almotriptan—Headache—Capecitabine—breast cancer	3.16e-05	0.000181	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—breast cancer	3.16e-05	0.000181	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—breast cancer	3.16e-05	0.000181	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—breast cancer	3.14e-05	0.00018	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—breast cancer	3.13e-05	0.00018	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—breast cancer	3.12e-05	0.000179	CcSEcCtD
Almotriptan—Nausea—Docetaxel—breast cancer	3.09e-05	0.000178	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—breast cancer	3.09e-05	0.000177	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—breast cancer	3.09e-05	0.000177	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—breast cancer	3.07e-05	0.000176	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—breast cancer	3.03e-05	0.000174	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—breast cancer	3.03e-05	0.000174	CcSEcCtD
Almotriptan—Pain—Epirubicin—breast cancer	3.01e-05	0.000172	CcSEcCtD
Almotriptan—Nausea—Capecitabine—breast cancer	3e-05	0.000172	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—breast cancer	2.97e-05	0.00017	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—breast cancer	2.97e-05	0.00017	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.96e-05	0.00017	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—breast cancer	2.94e-05	0.000169	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—breast cancer	2.92e-05	0.000167	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—breast cancer	2.9e-05	0.000166	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—breast cancer	2.9e-05	0.000166	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—breast cancer	2.89e-05	0.000166	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—breast cancer	2.87e-05	0.000165	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—breast cancer	2.86e-05	0.000164	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—breast cancer	2.81e-05	0.000161	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—breast cancer	2.8e-05	0.000161	CcSEcCtD
Almotriptan—Pain—Doxorubicin—breast cancer	2.78e-05	0.000159	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—breast cancer	2.78e-05	0.000159	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—breast cancer	2.78e-05	0.000159	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—breast cancer	2.77e-05	0.000159	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—breast cancer	2.69e-05	0.000155	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—breast cancer	2.68e-05	0.000154	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—breast cancer	2.66e-05	0.000153	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—breast cancer	2.66e-05	0.000152	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—breast cancer	2.59e-05	0.000149	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—breast cancer	2.57e-05	0.000147	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—breast cancer	2.57e-05	0.000147	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—breast cancer	2.57e-05	0.000147	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—breast cancer	2.52e-05	0.000145	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—breast cancer	2.49e-05	0.000143	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—breast cancer	2.48e-05	0.000142	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—breast cancer	2.4e-05	0.000138	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—breast cancer	2.4e-05	0.000137	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—breast cancer	2.39e-05	0.000137	CcSEcCtD
Almotriptan—Rash—Methotrexate—breast cancer	2.37e-05	0.000136	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—breast cancer	2.37e-05	0.000136	CcSEcCtD
Almotriptan—Headache—Methotrexate—breast cancer	2.35e-05	0.000135	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—breast cancer	2.33e-05	0.000134	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—breast cancer	2.32e-05	0.000133	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—breast cancer	2.3e-05	0.000132	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—breast cancer	2.23e-05	0.000128	CcSEcCtD
Almotriptan—Nausea—Methotrexate—breast cancer	2.23e-05	0.000128	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—breast cancer	2.22e-05	0.000128	CcSEcCtD
Almotriptan—Rash—Epirubicin—breast cancer	2.22e-05	0.000127	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—breast cancer	2.21e-05	0.000127	CcSEcCtD
Almotriptan—Headache—Epirubicin—breast cancer	2.2e-05	0.000126	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—breast cancer	2.15e-05	0.000123	CcSEcCtD
Almotriptan—Nausea—Epirubicin—breast cancer	2.09e-05	0.00012	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—breast cancer	2.07e-05	0.000119	CcSEcCtD
Almotriptan—Rash—Doxorubicin—breast cancer	2.05e-05	0.000118	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—breast cancer	2.05e-05	0.000117	CcSEcCtD
Almotriptan—Headache—Doxorubicin—breast cancer	2.04e-05	0.000117	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—breast cancer	1.93e-05	0.000111	CcSEcCtD
Almotriptan—CYP2D6—Metabolism—CYP3A4—breast cancer	3.69e-06	4.08e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RELA—breast cancer	3.68e-06	4.07e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—breast cancer	3.66e-06	4.05e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP17A1—breast cancer	3.65e-06	4.04e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	3.65e-06	4.04e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—breast cancer	3.64e-06	4.02e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MDM2—breast cancer	3.63e-06	4.02e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1B1—breast cancer	3.63e-06	4.01e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAF1—breast cancer	3.62e-06	4.01e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO1—breast cancer	3.61e-06	4e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS1—breast cancer	3.61e-06	4e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—breast cancer	3.61e-06	3.99e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MTOR—breast cancer	3.61e-06	3.99e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—breast cancer	3.61e-06	3.99e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RELA—breast cancer	3.61e-06	3.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.6e-06	3.98e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—breast cancer	3.58e-06	3.96e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—breast cancer	3.57e-06	3.95e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.56e-06	3.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.55e-06	3.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2D6—breast cancer	3.54e-06	3.92e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MTOR—breast cancer	3.54e-06	3.91e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—breast cancer	3.54e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NCOR1—breast cancer	3.53e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—breast cancer	3.53e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.53e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.48e-06	3.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOA2—breast cancer	3.48e-06	3.85e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—breast cancer	3.47e-06	3.84e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NCOA1—breast cancer	3.46e-06	3.83e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—breast cancer	3.45e-06	3.81e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—COMT—breast cancer	3.45e-06	3.81e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—breast cancer	3.43e-06	3.79e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—STK11—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—breast cancer	3.4e-06	3.76e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—breast cancer	3.39e-06	3.75e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—breast cancer	3.38e-06	3.74e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—breast cancer	3.38e-06	3.74e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—breast cancer	3.38e-06	3.73e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ITPR1—breast cancer	3.38e-06	3.73e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—FASN—breast cancer	3.37e-06	3.73e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DPYD—breast cancer	3.37e-06	3.72e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MED12—breast cancer	3.37e-06	3.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BCHE—breast cancer	3.36e-06	3.72e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—breast cancer	3.35e-06	3.71e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—breast cancer	3.35e-06	3.7e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—breast cancer	3.33e-06	3.68e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ERCC2—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC5A5—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDOA—breast cancer	3.31e-06	3.66e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—breast cancer	3.3e-06	3.65e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—breast cancer	3.28e-06	3.63e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—breast cancer	3.27e-06	3.62e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—breast cancer	3.25e-06	3.6e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—breast cancer	3.25e-06	3.59e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—breast cancer	3.25e-06	3.59e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—breast cancer	3.23e-06	3.58e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—breast cancer	3.23e-06	3.57e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—JUN—breast cancer	3.23e-06	3.57e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA3—breast cancer	3.22e-06	3.56e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NQO1—breast cancer	3.21e-06	3.54e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A1—breast cancer	3.21e-06	3.54e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—breast cancer	3.2e-06	3.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A2—breast cancer	3.19e-06	3.53e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—breast cancer	3.19e-06	3.53e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—COMT—breast cancer	3.17e-06	3.51e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—breast cancer	3.17e-06	3.5e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JUN—breast cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—breast cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—breast cancer	3.15e-06	3.49e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.15e-06	3.49e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NCOR1—breast cancer	3.15e-06	3.49e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—breast cancer	3.14e-06	3.47e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.14e-06	3.47e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—breast cancer	3.14e-06	3.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCG2—breast cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTR—breast cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CPT1A—breast cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—breast cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP3A4—breast cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—breast cancer	3.12e-06	3.45e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—breast cancer	3.12e-06	3.45e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—breast cancer	3.11e-06	3.44e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.11e-06	3.44e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ITPR1—breast cancer	3.11e-06	3.43e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—breast cancer	3.07e-06	3.4e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1B1—breast cancer	3.07e-06	3.4e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HPGDS—breast cancer	3.07e-06	3.39e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—breast cancer	3.06e-06	3.39e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—breast cancer	3.06e-06	3.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—breast cancer	3.05e-06	3.38e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HBA1—breast cancer	3.05e-06	3.37e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—breast cancer	3.04e-06	3.37e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—breast cancer	3.03e-06	3.36e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—breast cancer	3.02e-06	3.34e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.01e-06	3.33e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—breast cancer	2.99e-06	3.31e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—breast cancer	2.99e-06	3.31e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—breast cancer	2.99e-06	3.3e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—breast cancer	2.98e-06	3.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—breast cancer	2.98e-06	3.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACHE—breast cancer	2.98e-06	3.29e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ERCC2—breast cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—breast cancer	2.93e-06	3.24e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOA1—breast cancer	2.93e-06	3.24e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NCOR1—breast cancer	2.9e-06	3.21e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.9e-06	3.21e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—breast cancer	2.9e-06	3.21e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—breast cancer	2.89e-06	3.2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STK11—breast cancer	2.89e-06	3.19e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—breast cancer	2.89e-06	3.19e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—breast cancer	2.88e-06	3.18e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—breast cancer	2.83e-06	3.13e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—breast cancer	2.82e-06	3.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP17A1—breast cancer	2.82e-06	3.12e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—breast cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO1—breast cancer	2.79e-06	3.08e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS1—breast cancer	2.79e-06	3.08e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—breast cancer	2.79e-06	3.08e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—breast cancer	2.78e-06	3.07e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—breast cancer	2.76e-06	3.05e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.75e-06	3.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—breast cancer	2.75e-06	3.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2D6—breast cancer	2.74e-06	3.02e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—breast cancer	2.73e-06	3.02e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ERCC2—breast cancer	2.73e-06	3.01e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.71e-06	3e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—COMT—breast cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA2—breast cancer	2.68e-06	2.97e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—breast cancer	2.67e-06	2.96e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—breast cancer	2.67e-06	2.95e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—breast cancer	2.67e-06	2.95e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—breast cancer	2.64e-06	2.92e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—breast cancer	2.63e-06	2.91e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ITPR1—breast cancer	2.63e-06	2.91e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—breast cancer	2.62e-06	2.9e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—breast cancer	2.61e-06	2.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FASN—breast cancer	2.6e-06	2.88e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—breast cancer	2.59e-06	2.87e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BCHE—breast cancer	2.59e-06	2.87e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—breast cancer	2.59e-06	2.86e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—breast cancer	2.57e-06	2.84e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—breast cancer	2.56e-06	2.83e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC5A5—breast cancer	2.56e-06	2.83e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—breast cancer	2.54e-06	2.81e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—breast cancer	2.54e-06	2.8e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—breast cancer	2.53e-06	2.8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—breast cancer	2.53e-06	2.8e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—breast cancer	2.52e-06	2.79e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—breast cancer	2.49e-06	2.75e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—breast cancer	2.48e-06	2.75e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NQO1—breast cancer	2.47e-06	2.74e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A1—breast cancer	2.47e-06	2.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOR1—breast cancer	2.46e-06	2.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.46e-06	2.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—breast cancer	2.46e-06	2.72e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.46e-06	2.72e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—breast cancer	2.4e-06	2.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1B1—breast cancer	2.37e-06	2.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—breast cancer	2.36e-06	2.61e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—breast cancer	2.35e-06	2.6e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—breast cancer	2.35e-06	2.59e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—breast cancer	2.34e-06	2.59e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—breast cancer	2.33e-06	2.58e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.33e-06	2.57e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—breast cancer	2.33e-06	2.57e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—breast cancer	2.31e-06	2.55e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ERCC2—breast cancer	2.31e-06	2.55e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—breast cancer	2.31e-06	2.55e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—breast cancer	2.3e-06	2.55e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—breast cancer	2.28e-06	2.52e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA1—breast cancer	2.26e-06	2.5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STK11—breast cancer	2.23e-06	2.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—breast cancer	2.23e-06	2.47e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—breast cancer	2.2e-06	2.43e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—breast cancer	2.18e-06	2.41e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—breast cancer	2.17e-06	2.4e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—breast cancer	2.16e-06	2.38e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—breast cancer	2.15e-06	2.38e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—breast cancer	2.13e-06	2.36e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—breast cancer	2.09e-06	2.31e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—COMT—breast cancer	2.07e-06	2.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—breast cancer	2.06e-06	2.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—breast cancer	2.06e-06	2.28e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—breast cancer	2.04e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—breast cancer	2.03e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—breast cancer	2.03e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ITPR1—breast cancer	2.03e-06	2.24e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—breast cancer	2.01e-06	2.22e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—breast cancer	2.01e-06	2.22e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—breast cancer	2e-06	2.21e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—breast cancer	1.99e-06	2.21e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—breast cancer	1.99e-06	2.2e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—breast cancer	1.95e-06	2.16e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—breast cancer	1.95e-06	2.16e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—breast cancer	1.94e-06	2.15e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—breast cancer	1.92e-06	2.12e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.91e-06	2.12e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—breast cancer	1.91e-06	2.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOR1—breast cancer	1.9e-06	2.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—breast cancer	1.9e-06	2.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.9e-06	2.1e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—breast cancer	1.89e-06	2.09e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—breast cancer	1.89e-06	2.09e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—breast cancer	1.87e-06	2.07e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—breast cancer	1.82e-06	2.02e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—breast cancer	1.82e-06	2.01e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—breast cancer	1.8e-06	1.99e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—breast cancer	1.8e-06	1.99e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—breast cancer	1.79e-06	1.98e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—breast cancer	1.79e-06	1.98e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ERCC2—breast cancer	1.78e-06	1.97e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—breast cancer	1.78e-06	1.97e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—breast cancer	1.76e-06	1.95e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—breast cancer	1.74e-06	1.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—breast cancer	1.68e-06	1.85e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—breast cancer	1.65e-06	1.82e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—breast cancer	1.63e-06	1.81e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—breast cancer	1.6e-06	1.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—breast cancer	1.58e-06	1.75e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—breast cancer	1.43e-06	1.58e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—breast cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—breast cancer	1.4e-06	1.55e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—breast cancer	1.38e-06	1.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—breast cancer	1.24e-06	1.37e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—breast cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—breast cancer	1.22e-06	1.35e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—breast cancer	1.21e-06	1.34e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—breast cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—breast cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—breast cancer	1.09e-06	1.21e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—breast cancer	1.08e-06	1.19e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—breast cancer	1.07e-06	1.18e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—breast cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—breast cancer	1e-06	1.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—breast cancer	9.32e-07	1.03e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—breast cancer	8.93e-07	9.88e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—breast cancer	8.52e-07	9.42e-06	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—breast cancer	8.22e-07	9.09e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—breast cancer	6.96e-07	7.7e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—breast cancer	6.58e-07	7.27e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—breast cancer	5.37e-07	5.94e-06	CbGpPWpGaD
